Friday, October 24, 2014
YOLO COUNTY NEWS
99 CENTS

Novozymes, Monsanto announce new $300 million pact

By
From page A3 | December 11, 2013 |

Two companies that are international powerhouses in the bioagricultural field — both of which have long-standing research-and-development operations in Davis, employing dozens of Ph.D.s — announced a $300 million cooperative agreement Tuesday.

Novozymes and Monsanto will enter into “a long-term strategic alliance to transform research and commercialization of sustainable microbial products that will provide a new platform of solutions for growers around the world,” according to the announcement, datelined Copenhagen (where Novozymes is based) and St. Louis (where Monsanto’s headquarters are located).

“The BioAg Alliance is unique in the industry, bringing together Novozymes’ commercial bio-ag operations and capabilities within microbial discovery, development and production with Monsanto’s microbial discovery, advanced biology, field testing and commercial capabilities,” the statement said.

A Novozymes spokesperson told The Enterprise that some of the research under the BioAg Alliance will be done in Davis, but added, “It’s too early to tell exactly where the work will be done. Novozymes and Monsanto both have talented BioAg R&D teams around the world and we will be thinking about how to use our sites and talents in the best way to bring new products to market.

“We will still rely on colleagues across the global R&D organization for the important work necessary for success,” the spokesperson said. “As part of our evaluation, we will also consider our future talent needs.“

Said Peder Holk Nielsen, CEO of Novozymes, “Today, we forge a game-changing alliance with the potential to transform global agriculture. The combined capabilities of Novozymes and Monsanto create an innovation powerhouse with a unique opportunity and approach to unleash the transformational opportunity in naturally derived microbial solutions in agriculture.”

And Robb Fraley, chief technology officer of Monsanto, said, “Monsanto, Novozymes and the farmer customers we serve share a need to meet growing demand in a sustainable way, and investing in the research and development of agricultural biological technologies like microbials is another step in that direction and a natural extension of our core business.”

The statement portrayed the new alliance as mutually complementary.

Over the past decade, Novozymes has “leveraged its know-how and experience in industrial enzymes and microbial technologies to build global positions in the agricultural biologicals market with a broad and proven product portfolio,” the news release said. Novozymes’ annual revenue in 2012 neared $120 million.

“Combining its strengths within microbial discovery, application development and fermentation and its leadership position in the agricultural biologicals market, Novozymes brings an established and unique starting point for the alliance to accelerate from in both the short and long term,” the release added.

Monsanto has a research team working on microbial solutions and has one of the most extensive seeds and traits discovery, field-testing and commercial footprints in the industry, the statement said.

“All this will help accelerate microbial development through the alliance, enabling more farmers to get more solutions, faster. Last year the company introduced its agricultural biologicals platform and earlier this year acquired the assets of the agricultural company Agradis Inc. as it builds out its discovery capabilities in the microbial space.”

Under the new collaboration:

* “Monsanto and Novozymes will maintain independent and complementary internal and external discovery research programs to identify microbial targets with the potential to help farmers.”

* “Novozymes will be responsible for production and supply of the microbial solutions to Monsanto, building on its expertise within fermentation. Monsanto will serve as the lead for field testing, registration and commercialization of all alliance products.”

* “The companies will co-manage the alliance and co-fund research and development efforts.”

* “Monsanto will pay Novozymes an aggregate upfront payment of $300 million net in recognition of Novozymes’ ongoing business and microbial capabilities, and for Novozymes to supply alliance products.”

The statement indicated “Marketing responsibility for Novozymes’ current product portfolio in agricultural biologicals will be transferred to Monsanto, along with much of the Novozymes commercial organization currently responsible for that work. The two companies will work to ensure that existing customer relationships and know-how are maintained and further built on for short- and long-term success.”

Both companies “will benefit from profits on commercialized products resulting from this alliance and those products brought into the alliance by the parties. Through the alliance, the companies will also test and sell commercial microbial products purchased from other suppliers to bring additional value to farmers,” according to the statement.

The agreement is subject to the approval of national antitrust authorities. The alliance is expected to close in early 2014. Further terms of the alliance were not disclosed.

Comments

comments

.

News

 
Courageous Thompson tapped for cycling shrine

By Bruce Gallaudet | From Page: A1 | Gallery

UC researchers: How low-water can our landscapes go?

By Katie F. Hetrick | From Page: A1 | Gallery

 
Testimony begins in Winters murder trial

By Lauren Keene | From Page: A1 | Gallery

A-Z: Downtown Davis is the place to celebrate

By Kimberly Yarris | From Page: C1

 
Hong Kong protesters to vote on staying in streets

By The Associated Press | From Page: A2

 
Cloud business lifts Microsoft’s quarterly results

By The Associated Press | From Page: A2

 
Can you give them a home?

By Enterprise staff | From Page: A3 | Gallery

Scientists work to save endangered desert mammal

By Kat Kerlin | From Page: A3 | Gallery

 
Host families needed for students and teachers from Mexico

By Special to The Enterprise | From Page: A3

Halloween Dance set Friday for teens

By Enterprise staff | From Page: A3

 
Yoga and chanting workshop planned

By Enterprise staff | From Page: A3

Downtown menu: coffee, boba tea, dessert

By Wendy Weitzel | From Page: C3

 
Day of the Dead folk art class set

By Enterprise staff | From Page: A4

Flea Market planned Sunday

By Enterprise staff | From Page: A4

 
Enjoy A Taste of Capay at historic ranch

By Enterprise staff | From Page: A4

Red-hot tunes set at Blues Harvest

By Enterprise staff | From Page: A4

 
Learn how to fill a cornucopia with flowers

By Enterprise staff | From Page: A4

Video highlights Props. 1 and 2

By Special to The Enterprise | From Page: A4

 
‘Homeopathy at Home’ program planned

By Enterprise staff | From Page: A4

Celebrate origami at Davis library

By Enterprise staff | From Page: A4

 
Garden sale and open house features water-wise demos

By Special to The Enterprise | From Page: C4

Meet Poppenga at dog park Sunday

By Enterprise staff | From Page: A4

 
Bay Bridge art project needs $4 million to keep shining

By San Francisco Chronicle | From Page: A5 | Gallery

Weir honored, a year early

By Enterprise staff | From Page: A5

 
Explorit: Poison-proof your home with free lecture

By Lisa Justice | From Page: A6

For a good cause

By Fred Gladdis | From Page: A6

 
Americans, internationals make connections

By Enterprise staff | From Page: A6

Sutter auxiliary seeks volunteers

By Special to The Enterprise | From Page: A7

 
School board hopefuls discuss homework policy

By Jeff Hudson | From Page: A7

Project Linus seeks donations

By Enterprise staff | From Page: A9

 
Walkers welcome to join Sierra Club outings

By Enterprise staff | From Page: A9

.

Forum

The magic is long gone

By Creators Syndicate | From Page: B5

 
What’s next with Ebola?

By Letters to the Editor | From Page: A10

More theories on the abstention

By Letters to the Editor | From Page: A10

 
Rights beget responsibilities

By Letters to the Editor | From Page: A10

Water returns to its source

By Letters to the Editor | From Page: A10

 
A solution to the drought

By Letters to the Editor | From Page: A10

Experience nature’s treasures

By Letters to the Editor | From Page: A10

 
Subs have other concerns

By Letters to the Editor | From Page: A10

 
Tom Meyer cartoon

By Debbie Davis | From Page: A10

.

Sports

Bump, set, playoffs: Blue Devil girls clinch spot in postseason

By Thomas Oide | From Page: B1 | Gallery

 
Aggies expect a bonny meeting in Sacramento

By Bruce Gallaudet | From Page: B1

DHS footballers take on Pleasant Grove

By Enterprise staff | From Page: B1

 
Bye No. 2 comes at perfect time for nicked-up UCD

By Bruce Gallaudet | From Page: B1 | Gallery

Shhh. Are Aggie women BWC’s best-kept secret?

By Bruce Gallaudet | From Page: B1

 
UCD roundup: Preseason awards roll in for Aggie hoopster Hawkins

By Enterprise staff | From Page: B2 | Gallery

 
Sharks suffer from road woes

By The Associated Press | From Page: B12

.

Features

.

Arts

‘St. Vincent:’ Quite a character

By Derrick Bang | From Page: A11 | Gallery

 
Rumpledethumps to play at Village Homes Performers’ Circle

By Enterprise staff | From Page: A11 | Gallery

DMTC plans ‘My Fair Lady’

By Special to The Enterprise | From Page: A11

 
Czech Philharmonic Orchestra to perform

By Enterprise staff | From Page: A11

Calling all artists for upcoming show

By Enterprise staff | From Page: A11

 
.

Business

 
Car Care: Five things to ask yourself when shopping for a new vehicle

By Special to The Enterprise | From Page: B7

.

Obituaries

Lewis Melvin Dudman

By Special to The Enterprise | From Page: A4

 
Ann Foley Scheuring

By Special to The Enterprise | From Page: A4

.

Comics

Comics: Friday, October 24, 2014

By Creator | From Page: B3